GENE ONLINE|News &
Opinion
Blog

2021-08-18| Technology

Scientists Develop Drug Inducible Switch to Regulate Gene Therapy

by Ameya Paleja
Share To
As researchers develop innovative methods to deliver gene therapy, one problem remains - the protein output. Post-delivery, scientists have no control over how much protein the new gene will produce. Too little, the treatment would be ineffective, and too much and the protein can turn toxic for the recipient. To address this, researchers at the Children’s Hospital of Philadelphia (CHOP) have devised a switch that can be turned on with a drug.

GO Prime with only $1.49 now

LATEST
Topo-1 and FRα: Key Focus Areas and Major Collaborations in ADC Research – Part I
2024-07-23
Eli Lilly’s Tirzepatide Gets Approval in China for Weight Loss Management
2024-07-22
Roche Reports Positive Clinical Trial Results for Two Diabetes-Related Eye Disease Therapies
2024-07-19
7th Person in History Possibly Cured From HIV After Stem Cell Transplant for Acute Myeloid Leukemia
2024-07-19
Large RCT Finds Time-Lapse Imaging for Embryo Selection in IVF Does Not Improve Live Birth Rates
2024-07-19
Assessment of Supply Chain Risk Key to Improving Medicine Access
2024-07-18
SK Biopharma and Full-Life Sign US$571.5 Million Deal for Innovative Radiopharmaceutical FL-091
2024-07-18
EVENT
Scroll to Top